CHS 2017 Annual Report
The year 2017 was a remarkable one. Together, we have made noteworthy advancements
towards our vision for the inherited bleeding disorder community.
Hemophilia Today
Check out the latest issue of the CHS’ newsmagazine, Hemophilia Today, for information, current news and issues relevant to the bleeding disorder community.
Research
Research studies are crucial to the advancement of care and treatment and
often help move one step closer towards a better quality of life.
Get involved
“GivingTuesday” is a global giving movement taking place every year on the Tuesday after Black Friday. Make a donation, volunteer or help spread awareness. Get ready to give next Tuesday!
STRATEGIC PLAN | 2016‐2020
Jivi approved by Health Canada
Please CLICK HERE to read Bayer’s press release announcing the approval of Jivi, a new pegylated recombinant, B-domain deleted, extended half-life factor VIII concentrate.
Q&A about RFPs
We often receive questions about the tender process (RFP) for clotting factor concentrates. We produced a Q&A document which we hope will answer all your questions on the topic.
Recombinant factor concentrate charts
Please check out our updated charts listing the recombinant factor concentrates and their description.
